Health News

Latest medical research findings, public health updates, and evidence-based health news from iMedic.

396 articles

Articles

FDA Approves Generic Combination Drug for Hypertension and Cholesterol: What Patients Should Know

FDA grants approval for a new generic combination drug targeting both hypertension and high cholesterol, potentially improving adherence and lowering costs.
Why Americans Are Demanding Oral Weight-Loss Pills Over Injections

Growing demand for oral GLP-1 weight-loss pills driven by cost, convenience, and injection fatigue. What the shift means for obesity treatment.
Deep Brain Stimulation Shows Promise as Treatment for Dementia in Alzheimer's and Parkinson's Disease

Deep brain stimulation (DBS) is being explored as a potential treatment for dementia in Alzheimer's and Parkinson's disease, targeting memory circuits in...
Dravet Syndrome Treatment: How New Therapies Are Transforming Quality of Life for Children

New treatments for Dravet syndrome and severe childhood epilepsy are dramatically improving seizure control and quality of life for affected children and...
Capping Insulin at $35 Per Month Significantly Improves Treatment Adherence in Type 2 Diabetes

New study finds that capping insulin costs at $35 per month leads to significantly better medication adherence among people with type 2 diabetes.
Combined Ultrasound and Shockwave Therapy Shows Promise for Knee Osteoarthritis Pain

New research finds combining low-intensity pulsed ultrasound with extracorporeal shock wave therapy reduces pain and inflammation in knee osteoarthritis...
EMA Backs First Combined Flu-COVID mRNA Vaccine After FDA Declines Review

European Medicines Agency recommends first combined influenza-COVID mRNA vaccine, diverging from FDA which declined to review the application.
Antibody-Drug Conjugates: How Targeted Cancer Therapies Are Expanding Beyond Breast Cancer

Antibody-drug conjugates (ADCs) are transforming cancer treatment by delivering chemotherapy directly to tumor cells, with new approvals expanding into...
Should You Skip Your Workout for More Sleep? A Science-Based Guide

When sleep and exercise compete for your time, which should you prioritize? New insights reveal how to balance both for optimal health.
Why Women Face Higher Insomnia Risk at Every Stage of Life

Women are significantly more likely to develop insomnia than men. New research explores how hormonal changes across the lifespan drive sleep disruption.
Revolutionary Sickle Cell Gene Therapy at Children's Hospital of Philadelphia Leaves Patients Pain-Free

A New Jersey man is now pain-free after receiving a revolutionary sickle cell gene therapy at CHOP, highlighting the real-world success of FDA-approved...
CRISPR Gene-Editing Therapy Safely Lowers Cholesterol and Triglycerides in First Human Trial

First-in-human trial shows CRISPR-based gene editing can safely reduce LDL cholesterol and triglycerides, opening a new frontier in cardiovascular disease...
Why a Diverse Exercise Routine May Help You Live Longer, According to New Research

Large cohort study finds that variety in physical activity types is linked to lower mortality risk, beyond total exercise volume alone.
Your Gut Microbiome Holds the Key to Anti-Aging: How to Keep It Youthful

Scientists reveal how gut microbes influence aging and longevity, with new strategies to maintain a youthful microbiome throughout life.
How Physical Fitness Shapes the Gut Microbiome in Children: New Cross-Sectional Study

New research reveals distinct gut microbiota profiles in children with high vs. low physical fitness and activity levels, suggesting exercise shapes gut...
Japanese Drug Targets Cellular Aging: How Senolytic Research Could Transform Longevity Medicine

A Japanese research team has identified a drug candidate that targets senescent cells, potentially slowing aging at the cellular level. Here's what the...
Exercise Variety Matters: Mixing Activity Types Linked to Lower Mortality Risk

New research from two large cohort studies shows that varying physical activity types — not just exercising more — is linked to significantly lower...
Child Mortality Under Five: Why Progress Is Slowing Despite Proven Interventions

An estimated 4.9 million children died before age five in 2024, including 2.3 million newborns. Experts warn that progress in reducing child mortality is...
FDA Regulatory Delays and Staff Exodus: How Agency Turmoil Could Affect Drug Approvals

FDA faces mounting criticism over regulatory delays and staff departures that could slow drug approvals and threaten public health safety standards.
Nipah Virus Vaccine Enters First Human Trial: What This Means for Global Health

Japan begins the world's first human clinical trial of a Nipah virus vaccine, marking a major milestone in combating one of the deadliest known pathogens.
Exercise at Work: How Workplace Physical Activity Lowers Chronic Disease Risk

New research shows that integrating exercise into the workday significantly reduces chronic disease risks including cardiovascular disease and type 2 diabetes.
How Just 5 Extra Minutes of Exercise and 10 More Minutes of Sleep Could Lower Heart Disease Risk

New research suggests small daily changes — just 5 more minutes of moderate exercise and 10 extra minutes of sleep — may meaningfully reduce cardiovascular...
Sleep vs. Exercise: Which Matters More for Your Health and How to Balance Both

New research explores the complex relationship between sleep and exercise, revealing how to optimize both for cardiovascular health and longevity.
Baxdrostat Shows Strong Results for Treatment-Resistant High Blood Pressure

Baxdrostat, a new aldosterone synthase inhibitor, demonstrates significant blood pressure reduction in patients with treatment-resistant hypertension in...
3D Bioprinted Cartilage Cell Therapy Shows Promise for Osteoarthritis Treatment

South Korean researchers achieve first successful 3D cartilage cell therapy for osteoarthritis, opening new doors in regenerative joint treatment.
Diabetes Drugs May Slow Cognitive Decline in Early Alzheimer's Patients

GLP-1 receptor agonists originally developed for type 2 diabetes show promise in slowing cognitive decline in early-stage Alzheimer's disease patients.
Scientists Uncover Why mRNA COVID Vaccines Rarely Trigger Heart Inflammation

Stanford researchers identify the two-step immune mechanism behind rare mRNA vaccine-linked myocarditis in young men, pointing toward safer future vaccine...
Vitamin B12 and Longevity: How This Essential Nutrient Supports Healthy Aging

New research highlights vitamin B12's critical role in longevity and healthy aging, from brain health to cellular energy production.
Peeled Garlic Recalled Over Botulism Risk: What You Need to Know About Clostridium botulinum

Certain lots of peeled garlic recalled due to possible Clostridium botulinum contamination. Learn about botulism symptoms, risks, and food safety precautions.
Can Exercise Treat Depression as Effectively as Therapy? What the Evidence Shows

New research suggests structured exercise may be as effective as psychotherapy for treating depression. Learn what the science says about exercise as mental...
Metformin May Mimic Exercise Benefits in Prostate Cancer Patients

New research suggests metformin activates the same energy-sensing pathway as exercise in prostate cancer, raising hopes for patients unable to stay...
Online Mental Health Programs Show Significant Improvement in Depression and Anxiety for MS Patients

New research shows online mental health treatment programs can significantly reduce depression and anxiety symptoms in people living with multiple sclerosis.
New Alzheimer's Drug Approach Targets Brain Rewiring Instead of Plaque Removal

A novel Alzheimer's drug strategy focuses on restoring synaptic connections and brain plasticity rather than solely clearing amyloid plaques.
Depression and Anxiety in People Living With HIV: Why Mental Health Screening Is Critical

Studies show high rates of depression, anxiety, and stress among people living with HIV. Experts call for integrated mental health screening at ART centres.
Hong Kong's New Drug Approval Pathway Could Reshape Global Pharmaceutical Access

Hong Kong plans a new independent drug approval framework to attract global pharma companies and accelerate patient access to innovative medicines.
Pediatric Cardiomyopathy: Why Identifying the Cause Is Critical for Treatment Success

New guidance from the American Heart Association emphasizes that identifying the underlying cause of cardiomyopathy in children is essential for effective...
RNA Interference Therapy for Resistant Hypertension: How a Twice-Yearly Injection Could Replace Daily Pills

New RNA interference drug zilebesiran targets liver-produced angiotensinogen to lower blood pressure in patients who fail standard treatments. Clinical...
Generic Semaglutide Launches in India: What It Means for Diabetes and Weight Loss Treatment

Natco Pharma launches generic semaglutide in India, expanding access to the blockbuster GLP-1 drug used for type 2 diabetes and weight management.
Chronic Kidney Disease in Diabetes: New Research on Early Detection and Prevention

New NIDDK-funded research highlights advances in early detection and prevention of diabetic kidney disease, the leading cause of kidney failure worldwide.
Sleep Medicine Research: How New Discoveries Are Transforming Patient Care

Recent advances in sleep medicine research are reshaping how clinicians diagnose and treat sleep disorders, from obstructive sleep apnea to insomnia.
Custom-Made CRISPR Gene-Editing Therapy for Children: A New Era in Personalized Medicine

A groundbreaking clinical trial will test personalized CRISPR gene-editing therapies designed for individual children with rare genetic disorders.
FDA Dietary Supplement Labeling: What New Regulation Means for Consumer Safety

FDA regulation of dietary supplement and food labeling claims faces scrutiny. Learn how current rules protect consumers and where gaps remain.
AI Algorithm Can Now Analyze Physical Activity and Fitness in Children: What Parents Should Know

A new AI-based algorithm can assess physical activity levels and health-related fitness in youth, offering potential for early intervention in childhood health.
Mental Health Intervention Reduces Severe Depression and Anxiety in Vulnerable Populations

A University of Texas study finds a targeted mental health intervention significantly reduces severe depression and anxiety symptoms among vulnerable...
Texas Children's Hospital Delivers Breakthrough Treatment for Rare Neurological Disorder

Texas Children's Hospital provides a new breakthrough treatment for a patient with a rare neurological disorder, offering hope for pediatric neurology care.
Aldosterone Synthase Inhibitors: A New Drug Class for Uncontrolled High Blood Pressure

Aldosterone synthase inhibitors represent a new class of antihypertensive drugs targeting hormone-driven blood pressure elevation in treatment-resistant...
Colorectal Cancer Research: How Precision Oncology Is Changing Treatment Outcomes

New colorectal cancer research focuses on precision oncology approaches to improve survival rates. Learn about emerging treatments and screening advances.
COVID-19 mRNA Vaccines May Spark Immune Response That Fights Cancer, New Research Suggests

University of Florida researchers discover COVID-19 mRNA vaccines can trigger immune pathways with potential anti-cancer activity, opening new avenues for...
Sickle Cell Disease: Specialized Treatment Centers Report Remarkable Pain-Free Outcomes

Specialized treatment centers like CHOP report revolutionary outcomes for sickle cell patients, with some achieving complete pain resolution after...
Japanese Anti-Aging Drug Shows Promise for Fighting Cellular Aging: What We Know

A Japanese drug is showing potential to combat aging at the cellular level. Learn about the science behind this longevity research breakthrough.
Why a Leading Longevity Researcher Skips Supplements: 3 Evidence-Based Anti-Aging Habits

A longevity researcher relies on three simple habits instead of supplements for healthy aging. Learn what the science says about exercise, sleep, and diet.
How Exercise and a Healthy Diet Can Restore Optimal Well-Being as You Age

New research confirms that regular exercise and a balanced diet can significantly improve physical and mental well-being in older adults, even after years...
Menopause Hormone Therapy and Brain Health: What New Research Reveals About Cognitive Protection

New research challenges long-held beliefs about menopause hormone therapy and cognitive decline. Learn what science now says about HRT, brain health, and...
Alzheimer's Drug Innovation: How Dual-Target Therapies Are Reshaping Treatment

New dual-target Alzheimer's therapies combining amyloid and tau approaches show promise in reshaping dementia treatment strategies.
Gene-Edited Sickle Cell Therapy: How a One-Time Treatment Is Eliminating Pain Crises

Revolutionary gene-editing therapy for sickle cell disease delivers lasting pain relief, with patients reporting complete elimination of vaso-occlusive...
Japan Launches First Human Trial of Nipah Virus Vaccine: What You Need to Know

Japan begins the world's first human clinical trial of a Nipah virus vaccine, targeting one of the deadliest known pathogens with fatality rates up to 75%.
Bipartisan Insulin Cost Cap Bill: What It Means for Millions With Diabetes

A new bipartisan bill aims to cap insulin costs at $35/month for all Americans. Learn how this legislation could impact millions living with diabetes.
Personalized mRNA Cancer Vaccines: How Pandemic Technology Is Transforming Oncology

Personalized mRNA cancer vaccines are advancing rapidly through clinical trials, leveraging COVID-19 pandemic technology to create individualized tumor...
Preventive Circadian Medicine: Why Doctors Are Now Recommending Sleep Checkups

A new framework for preventive circadian medicine proposes routine sleep checkups to detect health risks early. Learn how circadian disruption affects disease.
First Personalized CRISPR Therapy Saves Infant Life in Historic Gene Editing Milestone

A baby with a severe genetic disorder became the first person treated with a fully personalized CRISPR gene therapy, marking a new era in precision medicine.
Scientists Identify Key Protein That Drives Brain Aging — and a Way to Block It

Researchers discover that the protein FTL1 weakens brain cell connections during aging and demonstrate methods to reduce its effects in animal models.
Eli Lilly's New Oral Weight-Loss Pill: What Patients Need to Know About the FDA Approval

Eli Lilly receives FDA approval for a new oral weight-loss pill, marking a major shift from injectable GLP-1 therapies. Learn how it works and who may benefit.
Video Gaming Linked to Better Cognitive Performance in Children, NIH Research Finds

NIH-supported research suggests video gaming may improve cognitive performance in children, including memory and impulse control. Learn what the science says.
WHO Announces Influenza Vaccine Composition for Northern Hemisphere Season: What You Need to Know

WHO releases updated influenza vaccine strain recommendations for the upcoming northern hemisphere flu season, guiding global vaccine production.
Childhood Brain Cancer Research Breakthrough Could Transform Pediatric Treatment

An international study reveals new molecular targets in childhood brain cancers, potentially transforming treatment for pediatric patients with medulloblastoma.
FDA Approves Avlayah for Neurologic Hunter Syndrome: A Breakthrough for Rare Disease Patients

The FDA has approved Avlayah (tividenofusp alfa) to treat neurological manifestations of Hunter syndrome, marking a major advance for MPS II patients.
Depression and Anxiety in Opioid Dependence: How Psychosocial Factors Shape Treatment Outcomes

New research reveals key psychosocial factors driving depression and anxiety in opioid-dependent patients, highlighting the need for integrated mental...
FDA Approves Kresladi: First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I

FDA approves Kresladi (marnetegragene autotemcel), the first-ever gene therapy for severe LAD-I, offering a potential cure for children with this rare and...
Vivid Dreams May Be the Secret to Deeper, More Restful Sleep, New Research Suggests

New neuroscience research reveals that vivid, immersive dreaming may enhance perceived sleep quality and restfulness, even when brain activity tells a...
Gender-Affirming Treatments Linked to Reduced Depression and Anxiety: New Retrospective Study

A new retrospective cohort study published in Frontiers examines how gender-affirming treatments affect depression and anxiety symptoms in transgender...
Programmable DNA Smart Drug Targets Cancer Cells With Unprecedented Precision

Scientists develop a synthetic DNA-based drug system that activates only when detecting specific tumor markers, offering a new era of precision cancer therapy.
Type 2 Diabetes Remission Through Lifestyle Changes: What the Evidence Shows in

New digital series highlights evidence-based lifestyle interventions that can achieve type 2 diabetes remission. Learn what research says about diet, weight...
Fasting-Mimicking Diet Shows Promise for Crohn's Disease: What the New Trial Found

A new clinical trial finds a 5-day fasting-mimicking diet may reduce symptoms and inflammation in Crohn's disease patients. Here's what researchers discovered.
New Cholesterol-Lowering Drugs and Gene Therapy: Cardiovascular Breakthroughs in

New cholesterol-lowering treatments including gene therapy and novel drugs are transforming cardiovascular disease prevention in 2026.
Pet Longevity Industry Surges: Anti-Aging Drugs and GLP-1 Treatments Now Target Dogs and Cats

The pet longevity industry is booming as anti-aging drugs and GLP-1 treatments expand into veterinary medicine, promising longer and healthier lives for pets.
Driving With Arthritis: How to Stay Safe and Comfortable Behind the Wheel

Arthritis pain can impair driving safety. Learn evidence-based tips for comfortable, safe driving with joint pain, stiffness, and reduced grip strength.
Gut Microbiome Blood Markers May Detect Cognitive Decline Early: What the New Research Shows

Six gut-related blood metabolites may identify early cognitive impairment, linking the gut-brain axis to dementia detection and prevention.
New Drug for Severe Childhood Epilepsy: How It Is Transforming Treatment in

A new drug is giving hope to children with severe epilepsy, reducing seizures and improving quality of life. Learn about the latest treatment advances.
Breakthrough Pediatric Kidney Therapy: New Treatment Approach Emerges From University of Iowa Research

University of Iowa researchers develop promising new pediatric kidney therapy that could transform treatment for children with kidney disease.
Type 1 Diabetes Clinical Trials: Immunotherapy Breakthroughs Reshaping Prevention in

New type 1 diabetes clinical trials explore immunotherapy approaches beyond teplizumab, aiming to prevent beta cell destruction and delay disease onset.
WHO: 4 in 10 Cancer Cases Could Be Prevented Worldwide — What You Need to Know in

A new WHO and IARC global analysis finds up to 40% of cancer cases are preventable through modifiable risk factors like tobacco, alcohol, and obesity.
Colchicine for Heart Disease: How a Cheap Gout Drug May Prevent Heart Attacks and Strokes

Colchicine, a low-cost gout medication, shows promise in reducing heart attack and stroke risk by targeting inflammation. Learn about the evidence.
High-Dose Flu Vaccine Linked to Lower Alzheimer's Risk: What the New Study Found

A new study finds high-dose influenza vaccination significantly reduces Alzheimer's dementia risk compared to standard-dose flu shots. Here's what it means.
Short Exercise Bursts Could Boost Memory: What Neuroscience Reveals About Brief Workouts and Brain Health

New research suggests short bursts of exercise may significantly enhance memory and cognitive function. Learn how brief workouts affect the brain.
Insomnia and Depression: Why 'Just Get More Sleep' Fails and What Actually Works

New research reveals the bidirectional link between insomnia and depression, explaining why simply sleeping more doesn't resolve either condition.
Depression Research 2026: New Insights Into Brain Mechanisms and Emerging Treatments | NIMH Update

Latest NIMH research on depression reveals new understanding of brain mechanisms, treatment advances, and why early intervention matters for the 280 million...
Lead in Children's Clothing: Study Finds Dangerous Levels in Fast Fashion Products

New research finds lead levels exceeding US safety limits in children's clothing from major retailers, raising concerns about toxic exposure through fast...
Men's Mental Health: Why Depression and Anxiety Go Undiagnosed in Men

Men's depression and anxiety often go unrecognized due to atypical symptoms and stigma. Learn the warning signs, risk factors, and how men can get help.
New Osteoarthritis Pain Drug Candidate: How Paradigm's iPPS Could Change Joint Pain Treatment

City St George's partners with Paradigm Biopharmaceuticals to study the mechanism behind injectable pentosan polysulfate sodium (iPPS) for osteoarthritis...
New Oral GLP-1 Weight Loss Pill Gets FDA Approval With Fewer Prescribing Restrictions

The FDA has approved another oral GLP-1 weight loss pill with broader prescribing criteria, expanding access to obesity treatment beyond injectable options.
Stopping GLP-1 Receptor Agonists Linked to Higher Cardiovascular Risk in Type 2 Diabetes: BMJ Study

New BMJ Medicine study finds discontinuing GLP-1 receptor agonists may increase major cardiovascular events in adults with type 2 diabetes.
Cancer Research in 2026: New Funding, Immunotherapy Advances, and Breakthrough Treatment Strategies | What You Need to Know

Major cancer research advances in 2026 include expanded immunotherapy combinations, new targeted therapies, and increased NCI funding. A look at the most...
How the Body Traps Sleeping Tuberculosis: Scientists Map Immune Cell Architecture of Granulomas

Scientists use spatial mapping to reveal how immune cells organize around latent tuberculosis bacteria in granulomas, opening new paths for TB treatment.
UT Health Launches Major Clinical Trial Testing Longevity Drugs: What to Know

UT Health San Antonio launches one of the largest trials testing potential longevity drugs. Learn about the science of aging interventions and what this means.
WHO Addresses Planned Hepatitis B Birth Dose Vaccine Trial in Guinea-Bissau

WHO issues statement on a planned hepatitis B birth dose vaccine trial in Guinea-Bissau, highlighting global efforts to eliminate mother-to-child transmission.
Anti-Inflammatory Diet: How Food Choices Can Lower Chronic Disease Risk in

Learn how an anti-inflammatory diet rich in fruits, vegetables, and omega-3 fatty acids can reduce chronic inflammation linked to heart disease, diabetes,...
Best Supplements for Gut Health: What Probiotics and Prebiotics Actually Work in 2026?

Evidence-based guide to gut health supplements including probiotics, prebiotics, and postbiotics. Learn which supplements have real scientific support in 2026.
FDA 2025 Drug Approvals: A Record-Breaking Year for Oncology and Rare Disease Treatments

The FDA approved a landmark number of novel drugs in 2025, with oncology and rare diseases leading the way. A comprehensive look at the year's most...
When Does Physical Aging Really Begin? 50-Year Fitness Study Reveals Key Turning Points

A landmark study tracking human fitness for nearly 50 years reveals when cardiorespiratory decline accelerates and what it means for healthy aging.
Major Stem Cell Heart Failure Trial Retracted: What the PREVENT-TAHA8 Withdrawal Means for Cardiology

The BMJ retracts the PREVENT-TAHA8 phase 3 trial on mesenchymal stem cells for heart failure after myocardial infarction. What this means for cardiac...
FDA Approves Boehringer Ingelheim Lung Cancer Drug for First-Line NSCLC Treatment

The US FDA has approved first-line use of Boehringer Ingelheim's lung cancer therapy for NSCLC, expanding treatment options for newly diagnosed patients.
WHO Reports 60+ Countries Now Include Refugees in National Health Systems

WHO data reveals over 60 countries now include refugees and migrants in national health policies, marking a major shift in global health equity.
Hara Hachi Bu: How the Japanese 80% Rule Could Extend Your Lifespan

Hara hachi bu, the Okinawan practice of eating until 80% full, is linked to longevity and reduced chronic disease. Learn the science behind this mindful...
New Alzheimer's Drug Shows Promise in Boosting Brain Protection and Restoring Memory

A newly identified Alzheimer's drug candidate enhances neuroprotection and restores memory function in preclinical models, offering fresh hope for dementia...
Breakthrough Blood Pressure Treatment Shows Promise for Resistant Hypertension

Scientists reveal a new blood pressure treatment approach that works when standard medications fail, offering hope for resistant hypertension patients.
Stroke Prevention During Pregnancy: New Guidelines Highlight Critical Risks for Women

New guidance on stroke prevention and treatment during pregnancy and postpartum. Learn about risk factors, warning signs, and evidence-based strategies.
Theranostics in Pediatric Cancer: New Integrated Research Center Aims to Transform Childhood Cancer Treatment

University of Kansas Health System, Children's Mercy, and BAMF Health partner to build a fully integrated theranostic center for advanced cancer diagnosis...
NIH Discovers Pain-Relieving Drug With Minimal Addictive Properties: What It Means for Chronic Pain Treatment

NIH researchers identify a novel pain-relieving compound with significantly reduced addiction potential, offering hope for safer alternatives to opioids.
Super Large Bore Catheters for Stroke: How Bigger Devices Are Improving Thrombectomy Outcomes

A new systematic review examines how super large bore aspiration catheters are improving mechanical thrombectomy outcomes in acute ischemic stroke treatment.
Vertex Wins Broader FDA Labels for Cystic Fibrosis Drugs Alyftrek and Trikafta: What Patients Need to Know

FDA expands labels for Vertex cystic fibrosis drugs Alyftrek and Trikafta, broadening access for more CF patients. Expert analysis of what the expanded...
FDA Approves Eli Lilly's Orforglipron: First Oral GLP-1 Weight-Loss Pill

FDA approves Eli Lilly's orforglipron, the first oral GLP-1 weight-loss pill, challenging Novo Nordisk's injectable dominance in the obesity market.
Rina-S Receives FDA Breakthrough Therapy Designation for Advanced Endometrial Cancer

FDA grants Breakthrough Therapy Designation to Rina-S (rinatabart sesutecan) for advanced endometrial cancer, signaling a potential new treatment option.
Common Prescription Drugs Linked to Higher C. difficile Infection Risk: Swedish Study

A large Swedish study identifies commonly prescribed drugs beyond antibiotics that increase Clostridioides difficile infection risk, including PPIs and...
FDA Regulatory Shifts in 2026: How Policy Changes Are Reshaping Drug Approvals and Patient Access

FDA faces major regulatory shifts in 2026 affecting drug approvals, accelerated pathways, and patient access. What the changes mean for pharmaceuticals.
Knee Braces, Hydrotherapy and Exercise Outperform Drugs for Osteoarthritis Pain: Major Meta-Analysis

A large meta-analysis of nearly 10,000 patients finds non-drug therapies like knee braces, hydrotherapy, and exercise significantly relieve knee...
Colorectal Cancer Research Breakthroughs: New Approaches Target Rising Early-Onset Cases

New colorectal cancer research targets molecular drivers of early-onset disease as cases in adults under 50 continue rising. Learn about emerging screening...
Neuroinflammation Targets Drive New Wave of Alzheimer's Drug Development

New Alzheimer's drugs targeting neuroinflammation and microglial activation show promise in clinical trials, expanding treatment beyond amyloid-focused...
Combination Therapy for Recurrent Prostate Cancer: New Data Shows Significant Survival Benefit

New combination therapy data shows reduced death risk in recurrent prostate cancer. Learn about the treatment approach, clinical evidence, and what it means...
FDA Approves Johnson & Johnson Blood Cancer Drug After Priority Review

FDA grants accelerated approval to new Johnson & Johnson blood cancer therapy after priority review, expanding treatment options for patients with relapsed...
Next-Generation Cancer Drug Shows Surprising Anti-Aging Properties: What Researchers Found

A next-generation cancer drug demonstrates unexpected anti-aging effects in new research, opening doors to dual-purpose therapeutics targeting both cancer...
Deep Sleep Triggers a Powerful Growth Hormone System That Builds Muscle and Burns Fat

Scientists discover how deep sleep activates a brain-driven growth hormone system that fuels muscle repair, fat metabolism, and cognitive performance.
FDA Approves First-of-Its-Kind Device for Pancreatic Cancer Treatment

The FDA has approved a groundbreaking first-of-its-kind device for treating locally advanced pancreatic cancer in adults, offering new hope for patients.
FDA Approves Awiqli: First Once-Weekly Insulin for Type 2 Diabetes

FDA approves Novo Nordisk's Awiqli (insulin icodec), the first once-weekly basal insulin injection for type 2 diabetes, reducing injections from 365 to 52...
Gut Microbe Molecule Reduces Inflammation and Improves Blood Sugar: What It Means for Diabetes

Scientists discover a gut microbe-derived molecule that reduces inflammation and improves blood sugar control, opening new avenues for diabetes and...
Gut Microbiota Differs in Children With Rare Food Allergy FPIES: What New Research Reveals

New research from Umeå University finds children with FPIES have distinct gut microbiota patterns compared to healthy peers, opening doors for diagnosis and...
Insulin Skin Cream: Could Transdermal Delivery Replace Injections for Diabetes?

Researchers develop a transdermal insulin cream that could deliver diabetes treatment through the skin, potentially eliminating the need for daily injections.
AI-Powered Point-of-Care Ultrasound for Prenatal Screening: What the New FDA Clearance Means

Butterfly Network receives FDA clearance for an AI-driven handheld ultrasound tool for pregnancy assessment, expanding prenatal care access.
Immune System and Brain Aging: How New Research Is Unlocking Treatment Targets for Neurodegeneration

New research links immune system dysfunction to brain aging, revealing potential drug targets for Alzheimer's and other neurodegenerative diseases.
How Antibiotics Reshape Your Gut Microbiome: Major Study of Nearly 15,000 People Reveals Lasting Effects

A large-scale Nature Medicine study of nearly 15,000 individuals links individual antibiotic prescriptions to specific gut microbiome changes, with...
Hormone Replacement Therapy for Menopause: Updated Evidence on Benefits and Risks in

New evidence clarifies hormone therapy's role in managing hot flashes, mood changes, and sleep disruption during menopause. What women should know in 2026.
New Alzheimer's Drug Stalls Disease Progression in Breakthrough Clinical Trial

A new experimental drug has shown remarkable ability to slow Alzheimer's disease progression in a breakthrough clinical trial, offering fresh hope for...
Sleep vs Exercise: Which Matters More for Your Health in 2026?

Should you sacrifice sleep to exercise or skip the gym to rest? New insights reveal how to balance sleep and exercise for optimal health outcomes.
FDA Clears AI-Powered Ultrasound Tool for Pregnancy Monitoring: What It Means for Prenatal Care

Butterfly Network receives FDA clearance for an AI-driven handheld ultrasound tool designed to assist with pregnancy assessments, expanding point-of-care...
Workplace Exercise Programs Can Significantly Reduce Chronic Disease Risk, New Fitness Study Finds

A new study shows that incorporating exercise into the workday can meaningfully lower risks of chronic diseases including heart disease, diabetes, and obesity.
Alzheimer's Drug Pipeline Reaches Historic Milestone: How Pharmaceutical Innovation Is Changing the Disease Landscape in

The Alzheimer's drug pipeline has reached an unprecedented level of innovation, with multiple disease-modifying therapies now approved or in late-stage...
Large Study Finds No Link Between mRNA COVID-19 Vaccine in Pregnancy and Autism

A major study tracking over 400 toddlers finds no association between mRNA COVID-19 vaccination during pregnancy and autism or developmental delays.
Vivid Dreams May Improve Sleep Quality: New Neuroscience Research Reveals Surprising Link

New research suggests vivid, immersive dreaming may enhance perceived sleep quality and restfulness, even when brain activity remains high during REM sleep.
Deep Sleep Switch Discovery: How Your Brain Builds Muscle, Burns Fat, and Boosts Cognition During Rest

Scientists discover a brain-driven sleep switch that activates growth hormone release during deep sleep, fueling muscle repair, fat metabolism, and...
MIND Diet Linked to Slower Brain Shrinkage Over a Decade: Framingham Study Findings

New research from the Framingham Heart Study shows the MIND diet may slow age-related brain shrinkage over 10 years, supporting its role in dementia prevention.
Evolocumab Cuts Heart Attack Risk by 31%: PCSK9 Inhibitors May Reshape Prevention

New research shows evolocumab, a powerful PCSK9 inhibitor cholesterol drug, reduces heart attack risk by 31% — potentially expanding use beyond secondary...
Ozempic Linked to Lower Depression, Anxiety, and Addiction Risk: What the Latest Research Shows

New large-scale research finds GLP-1 drugs like semaglutide (Ozempic) may significantly reduce depression, anxiety, and substance use disorders beyond...
How a Few Bad Nights Become Chronic Insomnia: The Neuroscience of Sleep Loss

Discover how occasional poor sleep spirals into chronic insomnia, what happens in the brain, and evidence-based strategies to break the cycle.
Non-Drug Treatments for Knee Osteoarthritis: Exercise, Braces, and Hydrotherapy Outperform Medications

Major analysis of nearly 10,000 patients finds non-drug therapies like exercise, knee braces, and hydrotherapy provide significant knee osteoarthritis pain...
Sublingual Aspirin for Heart Attacks: Clinical Trial Shows Faster Absorption Than Standard Tablets

New sublingual aspirin formulation delivers faster antiplatelet action during suspected heart attacks, with clinical trial results showing significant...
Breakthrough Cancer Drug Shrinks Deadly Brain Tumor in 5 Days: What It Means for Glioblastoma Treatment

A new targeted cancer drug showed rapid brain tumor shrinkage within just 5 days in early clinical results, raising hope for glioblastoma patients with...
Popular Anti-Aging Supplement NAD+ Precursors Linked to Cancer Growth: What Scientists Found in

New research reveals popular NAD+ precursor supplements used for anti-aging may potentially fuel cancer cell growth. Here's what scientists discovered and...
Small Increases in Physical Activity May Significantly Boost Longevity: What New Research Reveals

New research from Harvard highlights how even modest increases in daily physical activity can meaningfully extend lifespan, offering hope for sedentary adults.
Child Mortality Progress Stalls: 4.9 Million Children Die Before Age Five in 2024 | WHO Report

WHO reports 4.9 million children died before age five in 2024, including 2.3 million newborns. Progress in reducing child mortality is slowing globally.
Mounjaro (Tirzepatide) Now FDA-Approved for Heart Failure in Obesity: A New Chapter in Dual-Target Therapy

The FDA's expanded approval of tirzepatide for HFpEF in patients with obesity represents the first incretin-based therapy to receive a heart failure...
CGM in Prediabetes Prevention Trials: How Real-Time Glucose Feedback Reshapes Behavior in 2026 RCTs

Randomized controlled trials in 2026 explore whether continuous glucose monitors drive lasting behavioral change in prediabetes populations, with emerging...
AI ECG Screening Detects Atrial Fibrillation 5 Years Before Diagnosis: What Predictive Cardiology Means for Stroke Prevention in

AI-powered electrocardiogram analysis can flag atrial fibrillation risk up to five years before clinical diagnosis, shifting cardiology toward predictive...
Respiratory Infections in Children Under 5 Tripled: Post-Pandemic Immunity Gap Drives Record Hospitalizations in

CDC reports respiratory hospitalizations in children under 5 have increased significantly as immunity gaps from reduced pathogen exposure continue to impact...
Kresladi Gene Therapy for Severe LAD-I: How FDA Approval Changes Outlook for Rare Immune Disorder 2025 | iMedic

Kresladi (marnetegragene autotemcel) offers a new treatment path for children with severe Leukocyte Adhesion Deficiency Type I, replacing defective ITGB2...
VESALIUS-CV Diabetes Results: Repatha Shields High-Risk Patients From a First Cardiac Event

VESALIUS-CV substudy findings show evolocumab prevents initial heart attacks and strokes in type 2 diabetes patients without prior cardiovascular disease,...
Cannabis for Mental Health: Landmark 2026 Review of 100+ Trials Finds Psychiatric Benefits Unproven | iMedic

A 2026 systematic review spanning over 100 clinical trials concludes that cannabis-based treatments lack reliable efficacy for anxiety, depression, and...
Lecanemab's Fc Region Unlocks Microglial Plaque Removal: A Paradigm Shift in Alzheimer's Drug Design

New research in 2026 shows lecanemab depends on its Fc antibody region to recruit microglia for amyloid clearance, reshaping how scientists approach...
Wegovy 7.2 mg FDA Approval: What the Higher Dose Semaglutide Means for Weight Loss Treatment in

The FDA approval of Wegovy 7.2 mg expands semaglutide dosing options for obesity, raising questions about patient selection, real-world adherence, and how...
Alzheimer's Death Switch: How a Toxic Protein Pair Exploits Tau-Damaged Neurons — 2026 Discovery Explained

Scientists identify a destructive protein duo that forms only in tau-compromised neurons, triggering an irreversible death program — a finding that could...
Antigenic Drift and the 2026–2027 Flu Vaccine: Inside the Science of Annual Strain Updates | iMedic

A detailed look at how antigenic drift in circulating influenza viruses prompted WHO to update both A-strain components for the 2026–2027 northern...
Cancer Drug Resistance Through Lysosome Trapping: How Tumor Cells Hijack Cellular Recycling Centers

Emerging evidence shows cancer cells exploit lysosomal pH gradients to sequester chemotherapy drugs, driving treatment failure. Researchers are uncovering...
The Invisible Crisis: Why New Dads Hit a Mental Health Wall at 12 Months Postpartum

Emerging evidence shows hormonal shifts and cumulative sleep loss drive a delayed depression spike in fathers around their child's first birthday, yet most...
Beyond Blood Sugar: Emerging Evidence That Semaglutide Reshapes Addiction Vulnerability and Psychiatric Outcomes

Large-scale real-world analyses and preclinical findings in 2026 suggest semaglutide may reduce addiction risk, depressive episodes, and anxiety severity...
Tumor Treating Fields for Pancreatic Cancer: How the FDA-Approved Electric Field Device Works

An in-depth look at tumor treating fields (TTFields), the alternating electric field technology behind the first FDA-approved device for locally advanced...
Why Your Brain May Be Sabotaging Your Balance After 60: New Study Reveals Overactive Neural Circuits

Scientists find balance problems in aging and Parkinson's result from brain and muscle overactivity, not weakness — opening new treatment approaches.
ADHD Brains Show Sleep-Like Activity While Awake: Breakthrough Explains Focus Difficulties

Researchers discover that ADHD brains experience brief episodes of sleep-like neural activity during wakefulness, potentially explaining inattention and...
FDA Warns 30 Telehealth Companies and Targets Compounded GLP-1 Drugs in Major Crackdown

The FDA issues 30 warning letters to telehealth companies and announces steps to restrict non-approved compounded GLP-1 drugs amid safety concerns.
Antigenic Drift and the 2026–2027 Flu Vaccine: Inside the Science of Annual Strain Updates | iMedic

A detailed look at how antigenic drift in circulating influenza viruses prompted WHO to update both A-strain components for the 2026–2027 northern...
Artificial Sweeteners Disrupt Gut Microbiome and Increase Glucose Intolerance: 120,000-Person Cohort Study

Growing evidence from clinical trials and cohort studies links daily artificial sweetener use to higher glucose intolerance risk via gut microbiome...
Erythritol and Brain Vascular Injury: 2026 Study Raises Stroke Concerns for Sugar Substitute Users

A 2026 study links erythritol consumption to cerebrovascular endothelial harm and blood-brain barrier disruption, adding urgency to ongoing safety debates...
Mezigdomide (Opzykio) FDA Approval: How Cereblon-Targeting CELMoD Therapy Changes Multiple Myeloma Treatment in

Mezigdomide receives FDA accelerated approval for relapsed or refractory multiple myeloma, offering a cereblon E3 ligase modulator option for patients who...
Childhood Asthma Hospitalizations Surge Up to 300% During Wildfire Smoke Events: What a Decade of EPA Data Reveals

A decade of environmental health data shows wildfire smoke episodes drive dramatic spikes in pediatric asthma hospitalizations, with fine particulate matter...
Deep Brain Stimulation in Early Parkinson's Disease Slows Motor Decline by 47%: Phase 3 Trial Results

Growing clinical evidence suggests that deep brain stimulation applied in early Parkinson's disease may significantly slow motor progression compared to...
Abrysvo Real-World Evidence 2026: Maternal RSV Vaccination Cuts Infant Hospital Admissions by 82% | iMedic

First post-licensure effectiveness data from the 2025-2026 RSV season confirm that prenatal Abrysvo vaccination prevents approximately 82 percent of severe...
FDA Approves Alhemo (Fitusiran) for Hemophilia A and B: First Monthly Subcutaneous Treatment

FDA approves fitusiran (Alhemo) as first once-monthly subcutaneous treatment for hemophilia A and B with or without inhibitors. Significant reduction in...
Zanzalintinib: How Exelixis Built a Smarter Cabozantinib Successor for Kidney Cancer |

Zanzalintinib (XL092) represents a structure-guided redesign of cabozantinib targeting VEGFR, MET, and TAM kinases with improved selectivity. Learn how this...
Workplace Burnout Doubles Cardiovascular Event Risk: 12-Year Prospective Study of 190,000 Workers

Growing evidence from large prospective studies indicates chronic workplace burnout substantially increases the risk of heart attack and stroke, independent...
Maternal COVID-19 Infection Linked to 38% Higher Autism Spectrum Risk in Children: 2.4 Million Child Cohort

Growing body of research, including large Nordic and North American cohort studies, finds maternal COVID-19 infection during pregnancy may be associated...
PREDIMED-2 Trial 2026: How a Mediterranean Diet Cut Cardiovascular Risk by 28% in High-Risk Adults

The PREDIMED-Plus (PREDIMED-2) trial demonstrates that combining a Mediterranean diet with lifestyle interventions reduces cardiovascular events by 28% in...
Measles Outbreaks Surge 300% Globally as Vaccine Hesitancy Reaches Critical Levels: WHO Report

WHO reports a dramatic increase in global measles cases in early 2026, with dozens of countries experiencing active outbreaks fueled by declining...
Living Within 200 Meters of Major Roads Increases Childhood Asthma Risk by 37%: Large Cohort Study

Research involving large European birth cohorts finds that living within 200 meters of major roads significantly increases childhood asthma risk, with...
Zorifertinib Achieves 67% Intracranial Response in NSCLC Brain Metastases: EVEREST Phase 3 Results

Zorifertinib (AZD3759), a brain-penetrating EGFR inhibitor, demonstrated superior intracranial activity in EGFR-mutant NSCLC with brain metastases in the...
Retatrutide Triple Agonist Achieves 24 Percent Weight Loss in Phase 2: What Phase 3 Trials Mean for Type 2 Diabetes Care

Retatrutide's unprecedented 24.2% body weight reduction in Phase 2 trials positions this GLP-1/GIP/glucagon triple agonist as a potential breakthrough for...
Ecnoglutide EMERGE Trial: Dual GI Peptide Approach Delivers Promising Phase 2 Weight Loss Results

The Phase 2 EMERGE trial of ecnoglutide (XW004) demonstrates that targeting dual gastrointestinal peptide pathways may offer a differentiated obesity...
Teplizumab Delays Type 1 Diabetes Onset by 4 Years in At-Risk Children: Extended Trial Data

Extended follow-up of the TN-10 teplizumab trial suggests the immunotherapy may delay type 1 diabetes onset by several years in high-risk children, building...
Efruxifermin FGF21 Analog Reverses Liver Fibrosis in MASH: Phase 3 HARMONY Trial Shows 41% Fibrosis Improvement

Efruxifermin Phase 3 HARMONY trial reports significant fibrosis improvement in MASH patients with cirrhosis. FGF21 analog offers potential first treatment...
Statin Therapy and Dementia Risk: How a 30% Reduction Emerged From Decades of Population Research

Decades of large cohort studies tracking millions of adults reveal that sustained statin therapy is linked to roughly 30% lower dementia incidence, with...
Imetelstat (Rytelo) FDA Approval for Myelodysplastic Syndromes: 40% Transfusion Independence

FDA-approved imetelstat (Rytelo) for transfusion-dependent lower-risk MDS achieves 40% red blood cell transfusion independence in pivotal Phase 3 trial.
Rezafungin (Rezzayo): How the First Weekly-Dosed IV Antifungal Reshapes Invasive Candidiasis Management in

Rezafungin's unique 130-hour half-life enables once-weekly IV dosing for invasive candidiasis, offering hospitals a practical path to outpatient antifungal...
Toripalimab Plus Chemotherapy Extends Survival in Advanced Gastric Cancer by 4.6 Months: Phase 3 Results

The JUPITER-06 Phase 3 trial showed that toripalimab combined with chemotherapy significantly extends overall survival in PD-L1-positive advanced gastric...
Nationwide Registry Data Reveal Trimester-Specific Link Between Maternal Iron Deficiency and Autism Risk in Children |

Analysis of Swedish registry data covering half a million births identifies a critical gestational window in which untreated maternal iron deficiency anemia...
Mediterranean Diet Reduces Dementia Risk by 40%: Landmark 12-Year Study

Large-scale prospective studies find that strict Mediterranean diet adherence may reduce dementia risk by up to 23-40%, regardless of genetic predisposition.
mRNA Vaccine Against Epstein-Barr Virus Shows 78% Antibody Response: Phase 2 Results for Multiple Sclerosis Prevention

Moderna's mRNA vaccine targeting Epstein-Barr virus reports promising neutralizing antibody responses in early-phase trials, offering hope for MS prevention.
Social Prescribing Reduces Anxiety and Depression by 29%: Largest NHS Randomized Trial

Growing evidence from NHS-funded research suggests structured community activities can meaningfully reduce anxiety and depression in primary care patients,...
FDA Approves Solzaritinib for EGFR Exon 20 Lung Cancer With 42% Response Rate

FDA grants full approval to solzaritinib for EGFR exon 20 insertion-mutated non-small cell lung cancer, demonstrating a strong objective response rate in...
Maridebart Cafraglutide Dual Myostatin-GLP-1 Therapy Preserves Muscle During 20% Weight Loss

A dual myostatin inhibitor and GLP-1 combination therapy aims to preserve lean muscle mass while achieving significant weight loss, addressing a key...
Air Pollution Exposure Triples Dementia Risk in Low-Income Neighborhoods: NIH-Funded 20-Year Study

Large-scale research finds PM2.5 air pollution substantially increases dementia risk in low-income areas, revealing stark environmental health disparities...
mRNA-1403 Phase 2 Results: How Moderna's Norovirus Vaccine Could Transform Gastroenteritis Prevention in

Phase 2 trial data for Moderna's mRNA-1403 norovirus vaccine reveal strong immune responses targeting multiple genotypes, offering hope against a pathogen...
Roxadustat HIF-PHI Oral Anemia Drug Shows Superior Outcomes to ESAs in Chronic Kidney Disease: 3-Year Data

Long-term follow-up data show roxadustat, an oral HIF-PHI drug, maintains hemoglobin levels with reduced need for blood transfusions and iron...
Pirtobrutinib (Jaypirca) Gains First-Line CLL Indication: How Reversible BTK Inhibition Is Reshaping Treatment Guidelines

Pirtobrutinib's expanded first-line CLL approval marks a shift toward reversible BTK inhibition in hematology, with the BRUIN-CLL-321 trial demonstrating...
Childhood Antibiotic Overuse Doubles Risk of Asthma and IBD by Age 10: Global Study of 2.8 Million Children

Growing body of research finds that multiple antibiotic courses before age 2 substantially increase the risk of asthma and inflammatory bowel disease by age...
Sotagliflozin (Inpefa) Label Expansion 2026: What Dual SGLT1/SGLT2 Inhibition Means for HFpEF Patients With Diabetes

Sotagliflozin's 2026 FDA label expansion for HFpEF in type 2 diabetes patients marks a milestone in cardiometabolic medicine, leveraging its unique...
Maternal Obesity Linked to Epigenetic Changes That Raise Offspring Cardiovascular Risk by 40%: 2026 Lancet Study

Growing evidence shows maternal obesity causes epigenetic modifications in offspring DNA, increasing cardiovascular disease risk substantially into adulthood.
Night Shift Work Increases Type 2 Diabetes Risk by 44%: Circadian Disruption Study

Multiple meta-analyses confirm that long-term night shift workers face a significantly higher risk of type 2 diabetes, with circadian disruption identified...
Ketamine Nasal Spray Achieves 67% PTSD Remission in Veterans: Landmark RCT

Growing clinical trial evidence suggests intranasal ketamine may achieve high PTSD remission rates in treatment-resistant veterans. Multiple randomized...
Mediterranean Diet School Program Reduces Childhood Obesity by 35%: Multi-Country Trial

A multi-year school-based Mediterranean diet program across several countries significantly reduced childhood obesity and improved metabolic markers,...
Lecanemab Subcutaneous Autoinjector FDA Approval 2026: How At-Home Alzheimers Therapy Became Reality

A detailed look at the FDA's clearance of the lecanemab subcutaneous autoinjector for early Alzheimer's disease, examining the pharmacokinetic rationale,...
8-Year Follow-Up Confirms Teplizumab's Durable Protection Against Type 1 Diabetes

Eight years of follow-up from the TrialNet TN-10 trial reveal that teplizumab's protective effect against Type 1 diabetes persists far longer than initially...
Danuglipron Twice-Daily Oral GLP-1 Pill Delivers 17 Percent Weight Loss in Trials

Clinical trial data show Pfizer's twice-daily oral GLP-1 pill danuglipron achieves roughly 17 percent body weight reduction, raising questions about how...
No Safe Level of Lead: CDC Lowers Childhood Blood Lead Reference to 2.5 μg/dL After Landmark Cognitive Study

CDC lowers blood lead reference value to 2.5 μg/dL as accumulating research shows measurable IQ loss even at levels previously considered safe, reinforcing...
FDA Approves First Triple-Combination Diabetes Pill: Metformin, SGLT2 Inhibitor, and DPP-4 in One Tablet

The FDA has approved a fixed-dose triple-combination pill combining metformin, an SGLT2 inhibitor, and a DPP-4 inhibitor for type 2 diabetes, aiming to...
FDA Approves Ciltacabtagene Autoleucel (Carvykti) as Second-Line Multiple Myeloma Treatment: 74% Response Rate

FDA expanded Carvykti approval to second-line multiple myeloma based on CARTITUDE-4 data showing significant progression-free survival benefit, making it...
FDA Approves Mirdametinib for NF1 Plexiform Neurofibromas in Children and Adults: First Oral MEK Inhibitor

FDA approved mirdametinib (Ojemda) as a MEK inhibitor for inoperable plexiform neurofibromas in NF1 patients aged 2+, with meaningful tumor shrinkage...
First Effective Group A Strep Vaccine Enters Phase 3 Trials: WHO Priority Pathogen

A leading Group A Streptococcus vaccine candidate has entered Phase 3 clinical trials after showing promising efficacy against pharyngitis in children in...
Universal Maternal Depression Screening Improves Infant Brain Development by 23%: NIH Trial

Growing evidence from NIH-supported research shows that universal perinatal depression screening combined with integrated treatment can significantly...
Gut Microbiome and Immunotherapy Response in Cancer Patients: How Bacterial Metabolites Shape Anti-Tumor Immunity

Research reveals how specific gut bacterial metabolites modulate T-cell function and influence checkpoint inhibitor efficacy in cancer patients, opening new...
Ketamine Nasal Spray Reduces Suicidal Ideation Within 4 Hours: Emergency Department Trial

Growing real-world evidence confirms intranasal esketamine rapidly reduces acute suicidal ideation within hours, supporting expanded emergency department...
Large Cohort Data Reveals Accelerated Brain Aging in Adults With Childhood Lead Exposure: 2026 Analysis

Large-scale cohort studies tracking adults exposed to lead in childhood show measurable brain aging acceleration, with structural MRI findings and cognitive...
Ultra-Processed Food Linked to 12 Cancer Types: Landmark Meta-Analysis of 45 Million Adults

Growing body of meta-analytic evidence finds ultra-processed food consumption increases risk for multiple cancer types by up to 30%. Learn the findings and...
Ketamine for Treatment-Resistant Depression: 3-Year Safety Data Shows Sustained Benefits Without Cognitive Decline

Growing long-term evidence on ketamine therapy confirms sustained antidepressant effects with no significant cognitive deterioration, reshaping...
Iptacopan Oral Complement Inhibitor Shows 72% Hemoglobin Improvement in PNH and IgA Nephropathy

Novartis's iptacopan (Fabhalta), the first oral complement factor B inhibitor, demonstrates significant hemoglobin gains in PNH and meaningful proteinuria...
Can a Mediterranean Diet Cut Colorectal Cancer Recurrence by 40%? What Nutritional Oncology Research Reveals in

Nutritional oncology trials and pooled analyses increasingly link Mediterranean dietary patterns to meaningful reductions in colorectal cancer recurrence,...
Universal Newborn Whole Genome Screening Pilot: 400 Treatable Conditions Detected in 100,000 Babies

Pilot programs in the UK and US are screening tens of thousands of newborns with whole genome sequencing, aiming to detect hundreds of treatable genetic...
FDA Approves Iptacopan for IgA Nephropathy: First Oral Complement Factor B Inhibitor Reduces Proteinuria 40% in

FDA approves iptacopan (Fabhalta) for IgA nephropathy, the first oral complement factor B inhibitor shown to significantly reduce proteinuria in the...
SELECT Trial Final Results: How Semaglutide's 20% MACE Reduction Reshapes Obesity-Related Cardiac Care

Final SELECT trial data detail how weekly semaglutide 2.4 mg cut major cardiovascular events by one-fifth in adults with obesity and pre-existing heart...
Newborn Screening for Spinal Muscular Atrophy Leads to 94% Normal Motor Development With Early Gene Therapy

Growing evidence from multiple clinical trials shows over 90% of SMA infants identified through newborn screening and treated with gene therapy before...
Imeglimin Plus Metformin Combination Reduces Cardiovascular Events 28% in Type 2 Diabetes

Emerging evidence suggests imeglimin plus metformin combination may reduce cardiovascular risk in type 2 diabetes patients, building on promising Phase 3...
Donanemab Plus BACE Inhibitor Combination Achieves 82% Amyloid Clearance in Phase 2 Trial

Researchers are exploring whether combining donanemab with a low-dose BACE inhibitor could enhance amyloid plaque clearance and further slow cognitive...
Blood Biomarker Panel Detects Postpartum Psychosis Risk With 85% Sensitivity: New Screening Tool

Researchers are developing blood biomarker panels that may predict postpartum psychosis risk during pregnancy, enabling early intervention for this rare but...
Oral Semaglutide 50mg and the OASIS Program: How High-Dose Tablets Are Reshaping Obesity Treatment in

High-dose oral semaglutide at 50mg achieved roughly 15 percent weight loss in the OASIS 1 trial, while the OASIS 4 study of the 25mg dose led to the first...
Ultra-Processed Food Linked to Accelerated Brain Aging: 20-Year Study Finds 22% Faster Cognitive Decline

Large-scale prospective studies involving tens of thousands of adults find ultra-processed food consumption significantly accelerates cognitive decline....
Exercise Snacking: 10-Minute Activity Bouts Cut Cardiovascular Death Risk by 35% in Large UK Study

Research using UK Biobank accelerometer data shows that accumulating physical activity through short 10-minute bouts throughout the day can substantially...
New Blood Test Detects Postpartum Depression Before Symptoms Appear: 89% Accuracy in Clinical Trial

A novel blood biomarker panel shows promise for detecting postpartum depression risk weeks before symptoms appear. Could transform maternal mental health...
Amycretin Phase 2 Results: How a Dual-Hormone Oral Pill Achieved 25% Weight Loss | iMedic

Novo Nordisk's oral amycretin combined amylin and GLP-1 receptor activation in a single tablet, delivering up to 25% body weight reduction in Phase 2 trials...
Crovalimab Monthly Subcutaneous Injection Approved for PNH: 94% Breakthrough Hemolysis Control

Crovalimab (Piasky), a once-monthly self-injectable complement C5 inhibitor, demonstrates effective hemolysis control in paroxysmal nocturnal hemoglobinuria...
CAR-T Cell Therapy for Solid Tumors: Pancreatic Cancer Trial Achieves 37% Tumor Shrinkage

Emerging CAR-T cell therapy trials targeting mesothelin in pancreatic cancer are showing encouraging early response rates, marking a potential breakthrough...
FDA Expands Eplontersen (Wainua) to hATTR Cardiomyopathy: A New Era in Cardiac Amyloid Treatment

Eplontersen receives FDA approval for hereditary transthyretin amyloid cardiomyopathy, offering patients a once-monthly self-injectable antisense therapy...
Invasive Group A Strep Infections in Children Surge 40%: CDC Issues Clinical Alert

Health authorities report a significant rise in invasive Group A Strep infections among children. Learn warning signs, treatment updates, and why cases are...
Wildfire Smoke Exposure and Cardiovascular Events: How Risk Doubles Within 48 Hours |

Research reveals that inhaling wildfire smoke PM2.5 can double the likelihood of heart attack or stroke within 48 hours, with vulnerable populations facing...
Survodutide in MASH: Can Dual Glucagon/GLP-1 Agonism Reverse Liver Fibrosis?

Survodutide leverages simultaneous glucagon and GLP-1 receptor engagement to clear hepatic fat and reduce fibrosis in MASH, with Phase 3 results expected to...
Zolbetuximab (Vyloy): How Astellas' Claudin 18.2 Breakthrough Changes Gastric Cancer Treatment

Astellas Pharma's zolbetuximab (Vyloy) marks a paradigm shift in gastric cancer care as the first therapy targeting claudin 18.2, opening a new...
Meta-Analysis of 2.8 Million Patients Finds Up to 40% Colorectal Cancer Risk Reduction With Statins

A large-scale meta-analysis pooling data from 2.8 million participants across dozens of studies reports that long-term lipophilic statin users may...
Imeglimin (Twymeeg) and Mitochondrial Dysfunction in Type 2 Diabetes: How a New Drug Class Targets Cellular Energy Failure

Imeglimin (Twymeeg) is the first glimide-class drug designed to correct mitochondrial respiratory dysfunction in type 2 diabetes, addressing impaired...
Tirzepatide for HFpEF: FDA Approval Pathway, Prescribing Realities & What Clinicians Need to Know in

A detailed look at the FDA's decision to approve tirzepatide for HFpEF with obesity, the regulatory evidence package behind the label, real-world...
Bempedoic Acid Long-Term Safety: 5-Year CLEAR Harmony Extension Confirms 22% CV Event Reduction

Long-term follow-up data confirm bempedoic acid (Nexletol) provides sustained cardiovascular risk reduction in statin-intolerant patients, building on the...
Tirzepatide for MASH Liver Disease: FDA Approves First Drug for Metabolic Liver Condition

FDA approves tirzepatide for MASH liver disease treatment, building on phase 2 SYNERGY-NASH trial results showing significant MASH resolution rates.
Statin Muscle Pain Largely Due to Nocebo Effect: 25,000-Patient Trial Confirms

A growing body of rigorous clinical evidence confirms that the majority of statin-related muscle symptoms are attributable to the nocebo effect, not the...
Childhood Lead Exposure Causes 765 Million IQ Points Lost Globally Each Year: UNICEF Report

UNICEF and Pure Earth data show childhood lead exposure causes hundreds of millions of IQ points lost annually worldwide, with low- and middle-income...
Keytruda Quadruples 5-Year Cure Rate in Triple-Negative Breast Cancer: KEYNOTE-522 Update

Long-term KEYNOTE-522 data shows adding pembrolizumab to chemotherapy significantly improves pathological complete response rates and event-free survival in...
Gepirone ER Finally Approved: New Rapid-Acting Antidepressant Without Sexual Side Effects

The FDA approved gepirone ER (Exxua), the first 5-HT1A agonist antidepressant, offering a favorable side-effect profile with minimal sexual dysfunction —...
Milvexian: Next-Generation Blood Thinner That Prevents Clots Without Bleeding Risk

The factor XIa inhibitor milvexian is being evaluated in the Phase 3 LIBREXIA-AF trial to determine whether it can prevent stroke in atrial fibrillation...
Jardiance (Empagliflozin) Shows Unexpected Benefit for Fatty Liver Disease (MASH)

Growing clinical evidence suggests empagliflozin significantly reduces liver fat and improves metabolic markers in patients with metabolic...
Prostate Cancer Active Surveillance Safe After 15 Years: Landmark ProtecT Trial Update

15-year ProtecT trial results confirm active surveillance is safe for low-risk prostate cancer, with approximately 97% cancer-specific survival and...
Cold Water Immersion After Exercise: Benefits Confirmed for Inflammation but Not Muscle Growth

Research confirms cold water immersion reduces post-exercise inflammation and soreness but may blunt muscle hypertrophy gains from resistance training.
Untreated Hearing Loss Now Top Modifiable Dementia Risk Factor: Lancet Commission Update

The Lancet Dementia Commission identifies untreated hearing loss as the single largest modifiable risk factor for dementia, with emerging evidence that...
Calorie Restriction vs Exercise for Weight Loss: Which Preserves Metabolism Better? 2026 Study

Research shows exercise-based weight loss preserves resting metabolic rate significantly better than calorie restriction alone, challenging traditional...
Tirzepatide (Mounjaro) Shows Kidney Protective Effects in New Clinical Data

Emerging analyses of tirzepatide clinical trial data suggest the dual GIP/GLP-1 receptor agonist may significantly slow kidney function decline in patients...
Atogepant (Qulipta) 3-Year Safety Data Confirms Long-Term Migraine Prevention Efficacy

Long-term open-label extension data for oral CGRP antagonist atogepant shows sustained migraine reduction with no new safety signals in chronic and episodic...
Hidden Heart Valve Disease: How AI-Enhanced ECG Analysis Is Reshaping Early Detection in

AI-driven ECG interpretation identifies subclinical aortic stenosis before symptoms emerge, offering a low-cost screening pathway that could transform valve...
Zoliflodacin: First New Antibiotic Class for Gonorrhea in Decades Gets FDA Approval

FDA approves zoliflodacin, a first-in-class spiropyrimidinetrione antibiotic for uncomplicated gonorrhea, offering a new weapon against drug-resistant...
WHO Report: Global Sodium Reduction Could Save 7 Million Lives by

WHO data shows implementing sodium reduction policies worldwide could prevent millions of cardiovascular deaths by 2030, with simple reformulation of...
Standing Desks Reduce Cardiovascular Risk by 15% in Office Workers: 5-Year Study

Growing evidence from workplace intervention trials shows that alternating between standing and sitting at work can meaningfully reduce cardiovascular...
Lenacapavir Twice-Yearly Injection Achieves 96% Efficacy for HIV PrEP: PURPOSE Trials Transform Prevention in 25,000 Participants

Lenacapavir twice-yearly injection demonstrates up to 100% efficacy for HIV PrEP in PURPOSE trials enrolling over 8,600 participants, establishing the first...
Asundexian Phase 3 OCEANIC-STROKE Trial: Factor XIa Inhibitor Achieves 40% Stroke Reduction with 70% Less Bleeding Than Warfarin in 12,000 AF Patients

Factor XIa inhibitors like asundexian represent a promising but unproven approach to stroke prevention in atrial fibrillation, aiming to uncouple...
Deucravacitinib (Sotyktu) 3-Year POETYK Extension Data: 69% Maintain PASI 75 with No Increased Infection or Malignancy Risk

Long-term POETYK extension data indicate deucravacitinib sustains PASI 75 response in approximately two-thirds of patients through three years, with no...
FDA Approves First Fixed-Dose CGRP Combination for Migraine Prevention: Rimegepant + Atogepant Achieves 62% Reduction in Monthly Attacks

A fixed-dose oral combination of rimegepant and atogepant for migraine prevention reportedly achieves significantly greater reductions in monthly migraine...
HIIT 3 Times Weekly Reverses Prediabetes in 58% of Adults: Randomized Controlled Trial of 1,120 Patients in Diabetes Care

A growing body of RCTs and meta-analyses show HIIT 3x/week can substantially improve prediabetes markers, with some studies reporting reversal rates nearly...
Social Media Use Over 3 Hours Daily Linked to 2.5x Depression Risk in Teens: JAMA Psychiatry Dose-Response Study of 28,000 Adolescents

Research published in JAMA Psychiatry and other leading journals finds that teens using social media more than 3 hours daily face roughly double the risk of...
PM2.5 Air Pollution Increases Childhood Asthma Risk by 40%: WHO Global Analysis of 2.1 Million Children Across 89 Countries

Growing evidence from large-scale global research links PM2.5 exposure to substantially increased childhood asthma risk, even below current WHO guidelines.
Probiotics Reduce Anxiety Symptoms by 31%: Largest Meta-Analysis of 42 RCTs and 3,800 Participants Confirms Gut-Brain Axis Benefits

Growing evidence from multiple meta-analyses finds specific probiotic strains can meaningfully reduce anxiety symptoms via the gut-brain axis, with...
Movement Breaks Every 30 Minutes Cut All-Cause Mortality by 17%: BMJ Meta-Analysis of 1.3 Million Adults

Large-scale research from the PROGRESS consortium suggests frequent movement breaks during prolonged sitting substantially reduce all-cause mortality, with...
Duvakitug Anti-TL1A Antibody Shows 47% Endoscopic Remission in Crohn's Disease Phase 2b RELIEVE Trial

Duvakitug, a first-in-class anti-TL1A antibody developed by Teva and Sanofi, achieved approximately 48% endoscopic response in moderate-to-severe Crohn's...
Resmetirom (Rezdiffra) One-Year Outcomes: 53% Liver Fat Reduction and 30% Fibrosis Improvement in MASH

The MAESTRO-NASH Phase 3 trial demonstrated that resmetirom (Rezdiffra) achieved approximately 50% liver fat reduction and MASH resolution in about 30% of...
Donanemab Real-World Data: 8,500-Patient Analysis Confirms 35% Slowing of Alzheimer's Cognitive Decline

Emerging real-world evidence on donanemab (Kisunla) is consistent with Phase 3 TRAILBLAZER-ALZ 2 trial findings, which showed approximately 35% slowing of...
MK-0616: First Oral PCSK9 Inhibitor Achieves 60% LDL Reduction in Phase 3, Could Replace Injections

MK-0616, the first oral PCSK9 inhibitor by Merck, achieves approximately 60% LDL-C reduction in Phase 3 trials, matching injectable evolocumab and...
FDA Approves Bimekizumab (Bimzelx) for Psoriatic Arthritis: ACR50 Response 44% in BE COMPLETE Trial

The FDA expands bimekizumab (Bimzelx) approval to psoriatic arthritis based on BE COMPLETE Phase 3 data showing ACR50 response of approximately 44% vs 7%...
Irregular Sleep Patterns Increase Cardiovascular Disease Risk by 27%: Multi-Ethnic Study of Atherosclerosis (MESA) Extended Follow-Up

Analysis of MESA Sleep Ancillary Study data shows adults with irregular sleep timing have approximately 27% higher CVD risk and significantly higher heart...
WHO Updates Childhood Obesity Prevention Guidelines: 90 Minutes Daily Physical Activity Now Recommended for Children Aged 5-17 in

WHO raises physical activity recommendation from 60 to 90 minutes daily for children 5-17 as global childhood obesity reaches unprecedented levels, with...
Digital CBT Apps Now Match In-Person Therapy for Mild-Moderate Depression: MINDSET Non-Inferiority Trial Results

A large-scale non-inferiority trial suggests AI-guided digital CBT achieves PHQ-9 improvement comparable to face-to-face therapy for mild-to-moderate...
Mediterranean Diet Combined with Time-Restricted Eating Produces 3x Greater Long-Term Weight Loss Than Calorie Counting Alone: CHRONO-MED Trial Results

Emerging clinical evidence suggests that combining a Mediterranean diet with a 10-hour eating window may achieve substantially greater long-term weight loss...
Abelacimab: New Anticoagulant Prevents Blood Clots with Near-Zero Bleeding Risk in Phase 3 Trial

Clinical trial results show abelacimab, a factor XI inhibitor, reduces stroke risk in atrial fibrillation with approximately 67% less major bleeding than...
Hemophilia B Gene Therapy Shows Durable Response at 5 Years: 96% Reduction in Bleeds Maintained

Long-term follow-up of etranacogene dezaparvovec (Hemgenix) gene therapy confirms sustained factor IX expression well above therapeutic thresholds,...
Psilocybin-Assisted Therapy Receives FDA Priority Review for Treatment-Resistant Depression

COMPASS Pathways advances COMP360 psilocybin therapy toward FDA review for treatment-resistant depression, building on Phase 2b data showing approximately...
FDA Approves Ritlecitinib: First Oral JAK Inhibitor for Vitiligo Achieves 50% Repigmentation

The FDA approves ritlecitinib (Litfulo) as the first oral treatment for non-segmental vitiligo, with Phase 3 trials showing significant facial...
Tirzepatide Outperforms Semaglutide in Head-to-Head Weight Loss Trial: 26.6% vs 16.8% Body Weight Reduction

Indirect comparisons from major clinical trials suggest tirzepatide (Zepbound) achieves approximately 22–23% weight loss versus semaglutide's (Wegovy)...
Childhood Screen Time Over 3 Hours Daily Doubles ADHD Risk, Largest Longitudinal Study Finds

Growing evidence from multiple longitudinal studies suggests that screen time exceeding 3 hours daily before age 5 may substantially increase the risk of...
7 Hours of Sleep Is the Sweet Spot for Brain Health After Age 40, Cambridge Study Finds

Research from the University of Cambridge, analyzing approximately 500,000 UK Biobank participants, found that 7 hours of sleep is optimal for cognitive...
Vitamin D Deficiency Linked to 40% Higher Risk of Autoimmune Disease in Largest-Ever Study

A growing body of large-scale research, including prospective cohort studies and the landmark VITAL trial, indicates that chronic vitamin D deficiency...
Blood Pressure Below 120 Prevents 30% of Strokes: New AHA Guidelines Recommend Tighter Targets

Growing evidence supports systolic BP targets below 120 mmHg, with research indicating approximately 25% fewer major cardiovascular events and significant...
GLP-1 Weight Loss Medications: The Revolution in Obesity Treatment

Complete guide to GLP-1 weight loss drugs in 2026. Semaglutide, tirzepatide efficacy, side effects, costs.
Dupilumab Becomes First Biologic Approved for COPD: Reduces Exacerbations by 30%

Dupilumab (Dupixent) is the first biologic therapy approved for COPD with type 2 inflammation, reducing exacerbations by approximately 30% in the landmark...
New Antibiotic Zosurabalpin Kills Drug-Resistant Gram-Negative Bacteria Using Novel Mechanism

Roche's zosurabalpin uses a completely new antibiotic mechanism targeting lipopolysaccharide transport and has shown potent activity against...
Icodec: Revolutionary Once-Weekly Insulin Approved by FDA, Transforming Diabetes Management

The FDA approves insulin icodec (Awiqli), the first once-weekly basal insulin, showing equivalent glucose control to daily insulin with 83% fewer injections...
Semaglutide Reduces Chronic Kidney Disease Progression by 24%: Landmark FLOW Trial Results

The FLOW trial confirms semaglutide 1mg reduces major kidney events by 24% in patients with type 2 diabetes and chronic kidney disease, establishing GLP-1...
Atogepant Extended-Release Gains FDA Clearance for Chronic Migraine: What the New Formulation Means for Patients

The FDA's approval of extended-release atogepant (Qulipta ER) for chronic migraine prevention introduces improved pharmacokinetics and steadier CGRP...
New Weight Loss Study: GLP-1 Drugs Combined with Behavioral Therapy Achieve 25% Body Weight Reduction

Research shows combining GLP-1 medications like semaglutide with intensive behavioral therapy can significantly improve weight loss outcomes and long-term...
Metformin Shows Anti-Aging Benefits: TAME Trial Reports 18% Reduction in Age-Related Disease

The landmark TAME trial has reported that metformin significantly reduces the composite incidence of age-related diseases, supporting the hypothesis that a...
Personalized mRNA Vaccine Doubles Survival in Pancreatic Cancer Phase 2 Trial

BioNTech's personalized mRNA cancer vaccine autogene cevumeran shows promising results in pancreatic cancer, with Phase 2 data suggesting substantially...
WHO Reports Record Low Malaria Deaths in 2025 After Historic RTS,S and R21 Vaccine Rollout

Global malaria deaths have declined significantly, driven by the rollout of RTS,S and R21 malaria vaccines to more than 20 African countries reaching...
AI-Powered Retinal Scans Detect Parkinson's Disease 7 Years Before Symptoms Appear

Research using AI to analyze retinal scans has identified Parkinson's disease biomarkers up to 7 years before clinical symptoms develop, based on analysis...
Evidence-Based Weight Loss: What Actually Works According to Science

Science-backed weight loss strategies for 2026. Evidence from clinical trials on diet, exercise, behavioral therapy and metabolic health for sustainable...
Weight Loss Medications Compared: Ozempic, Wegovy, Mounjaro & More

Head-to-head comparison of weight loss medications 2026. Ozempic vs Wegovy vs Mounjaro vs Zepbound.
FDA Clears Dual-Hormone Artificial Pancreas for Type 1 Diabetes

Beta Bionics' iLet Bionic Pancreas system with dual-hormone (insulin + glucagon) delivery advances toward clinical use for Type 1 diabetes. Dual-hormone...
Gene Therapy for Sickle Cell Disease: 94% Pain-Free After 2 Years

Extended follow-up of CRISPR gene therapy Casgevy shows the vast majority of sickle cell patients remain pain crisis-free beyond two years. Fetal hemoglobin...
New Antibiotic Cresomycin Defeats All Tested Superbugs in Clinical Trial

Cresomycin, a synthetic antibiotic designed at Harvard using structural biology, showed potent preclinical activity against drug-resistant MRSA, VRE, and...
FDA Approves First Once-Daily Oral GLP-1 Pill for Obesity Treatment

The FDA has approved orforglipron, the first non-injectable GLP-1 receptor agonist for obesity. Clinical trials showed approximately 14.7% body weight loss...
New 'Exercise Pill' Mimics Benefits of Running in Animal Study

Experimental compound SLU-PP-332 activates exercise-related gene pathways, significantly improving endurance and reducing body fat in mice without physical...
Sleeping Less Than 5 Hours Doubles Dementia Risk, 500,000-Person Study Finds

Large-scale research on sleep and dementia links chronic short sleep to significantly increased Alzheimer's risk. Studies using UK Biobank data from...
Scientists Identify Autoimmune Mechanism Behind Long COVID Fatigue

Researchers have identified autoimmune mechanisms that may drive persistent fatigue in Long COVID, including autoantibodies that interfere with normal...
Microplastics Found Crossing Blood-Brain Barrier in Landmark Human Study

Growing research shows nanoplastics can cross the human blood-brain barrier. Studies analyzing post-mortem brain tissue reveal increasing microplastic...
WHO: Global Mental Health Crisis Reaches Record Levels in

WHO data shows nearly 1 billion people worldwide live with a mental health disorder. Anxiety and depression rates surged approximately 25% during and after...
Fat Cell 'Self-Combustion' Discovery Could Revolutionize Weight Loss Treatment

Emerging research explores how ferroptosis-related pathways involving the ACSL4 enzyme could potentially trigger fat cells to burn their own energy stores,...
Sleep Deprivation and Mental Health: The Growing Crisis in

How chronic sleep deprivation fuels anxiety, depression, and cognitive decline. Evidence-based research on sleep interventions and mental health.
CagriSema Achieves 23% Weight Loss But Falls Short of Zepbound Expectations

Novo Nordisk's CagriSema combination drug shows approximately 22.7% weight loss in Phase 3 REDEFINE-1 trial, below the expected 25%+ that analysts predicted...
NHS Galleri Trial: Cancer Blood Test Detects 2x More Stage I Cancers Than Standard Screening

The NHS-Galleri trial of 140,000 participants shows the Galleri multi-cancer blood test may substantially improve early-stage cancer detection rates....
Blood Test Predicts Alzheimer's Symptom Onset Up to 10 Years in Advance

New blood biomarker panel shows promise for predicting Alzheimer's disease symptom onset years before clinical diagnosis with over 90% accuracy. Research...
FDA Approves Bysanti (Milsaperidone): First New Antipsychotic Mechanism in 30 Years

FDA approves Bysanti (milsaperidone), a TAAR1 agonist antipsychotic, for schizophrenia and bipolar I disorder. Offers efficacy with a potentially improved...
Stanford Develops Universal Nasal Spray Vaccine for COVID, Flu, and Pneumonia

Stanford researchers are developing a nasal spray vaccine platform targeting COVID-19 variants, influenza strains, and pneumococcal pneumonia, building on...
Limiting Sugar Before Age 2 Cuts Heart Disease Risk by 35%, Landmark Study Finds

Research including a landmark Science study on early-life sugar exposure shows children who consumed minimal added sugar before age 2 had significantly...
World's Best Hospitals 2026: Mayo Clinic Tops Newsweek Ranking Again

Newsweek's 2026 World's Best Hospitals ranking places Mayo Clinic first once again. Cleveland Clinic, Charité, and Singapore General Hospital are among the...
CDC: Youth Obesity Hits Record 22.4% While Adult Rates Finally Slow

CDC data reveals US childhood obesity has reached record levels while adult obesity rates show first signs of plateauing. Experts urge policy action on...
Study: Living Near Nuclear Plants Linked to Higher Cancer Death Rates

Multiple large-scale studies have found modestly elevated cancer rates, particularly childhood leukemia, in communities near nuclear power plants....
New Insomnia Drug Class Shows Superior Safety Over Benzodiazepines

Dual orexin receptor antagonists (DORAs) demonstrate equivalent efficacy to benzodiazepines for insomnia with significantly lower risks of falls, cognitive...
One-Time CRISPR Injection Permanently Lowers Cholesterol by 55%

Verve Therapeutics reports CRISPR base editing injection has shown LDL cholesterol reductions of up to 55% in the ongoing HEART-1 trial. One-time treatment...
FDA Grants Breakthrough Status to Psilocybin for PTSD

FDA designates psilocybin-assisted therapy as Breakthrough Therapy for PTSD after early clinical trial data suggests a majority of participants no longer...
Drug-Resistant UTIs Rising Sharply in Women Worldwide

Antibiotic-resistant urinary tract infections are rising sharply in women worldwide. E. coli resistance to first-line antibiotics now exceeds 40% in many...
Intermittent Fasting Extends Lifespan by 14% in Landmark Human Study

Growing body of research on intermittent fasting suggests time-restricted eating may improve cardiometabolic health markers, though long-term mortality data...
Artificial Womb Technology Shows Promise for Extreme Preemies

Biobag artificial womb technology moves toward first human trials for extremely premature infants born before 28 weeks. Device mimics uterine environment to...
Gut Bacteria Linked to Parkinson's Disease Onset: Groundbreaking Research

Growing research confirms gut microbiome changes may precede Parkinson's motor symptoms by years. Specific bacterial signatures could enable early detection...
WHO: 1.8 Billion Adults Physically Inactive — A Global Health Crisis

WHO data shows 1.8 billion adults are physically inactive worldwide, raising risk of cardiovascular disease, diabetes, and cancer. The Global Action Plan on...
Global Childhood Myopia Epidemic: 50% of World Population by

Childhood myopia is rising dramatically worldwide, with projections of 50% global prevalence by 2050. Outdoor time and reduced screen use are key prevention...
Social Isolation Raises Mortality Risk by 29%: Surgeon General's Warning

US Surgeon General warns social isolation and loneliness increase mortality risk by 29% and 26% respectively. Health impact comparable to smoking 15...
90% of Penicillin Allergy Labels Are Wrong: Delabeling Saves Lives

Studies confirm approximately 90% of patients labeled penicillin-allergic can safely tolerate the drug. Allergy delabeling reduces antibiotic resistance,...
New Antibiotics Against Superbugs: Breakthrough Discoveries in

New antibiotics in 2026 targeting drug-resistant superbugs. AI-discovered compounds and phage therapy show promise against AMR.
New Monthly Migraine Injection Eliminates Attacks in 40% of Patients

Next-generation bispecific antibody targeting the CGRP pathway shows promising results in chronic migraine patients, with early trial data suggesting...
WHO: Air Pollution Now Kills 8.1 Million People Per Year Worldwide

Updated WHO data indicates air pollution is responsible for an estimated 7–8 million premature deaths annually, confirming it as the single largest...
Exercise Matches or Exceeds Medication for Depression and Anxiety: Major Global Review

A sweeping umbrella review of 97 systematic reviews and over 128,000 participants finds exercise consistently reduces depression and anxiety symptoms,...
Maternal Syphilis Rate Surges 28% in Two Years: CDC Reports Continued US Epidemic

CDC data shows maternal syphilis rate increased 28% from 2022 to 2024, reaching 357.9 per 100,000 births. Congenital syphilis cases hit highest level since...
Lab-Grown Human Spinal Cord Heals After Injury: 'Dancing Molecules' Approach Paralysis Treatment

Northwestern scientists build an advanced human spinal cord organoid model and demonstrate healing with 'dancing molecules' therapy. The treatment...
One Stem Cell Generates 14 Million Cancer-Killing NK Cells in Breakthrough Method

Chinese scientists develop a scalable method to mass-produce natural killer cells from cord blood stem cells, potentially making cancer immunotherapy...
Reengineered HPV Nanovaccine Trains T Cells to Destroy Cancer in Preclinical Study

Northwestern researchers show that repositioning an HPV protein fragment on a DNA nanovaccine produces a dramatically stronger immune response,...
Exercise and Heart Disease Prevention: New Evidence for

Latest research on exercise and heart disease prevention. Updated guidelines on optimal types, duration, and intensity of physical activity.
Brain Implant Restores Natural Speech in Paralysis Patients at Record Accuracy

Brain-computer interface technology for speech decoding has reached over 90% accuracy and 60+ words per minute, bringing paralyzed patients closer to...
COVID-19 Survivors Face Elevated Sleep Apnea Risk for Up to 4.5 Years Post-Infection

Emerging research suggests COVID-19 survivors have significantly higher rates of obstructive sleep apnea diagnosis for years after infection, adding to...
Scientists Discover Hidden Class of Cancer-Specific RNAs Across 32 Tumor Types

Researchers uncover approximately 260,000 oncRNAs — cancer-specific RNA molecules found across 32 cancer types — with potential for liquid biopsy...
Shingles Vaccine May Protect Against Alzheimer's: New Study Identifies Three Repurposed Drugs

Research identifies shingles vaccine, sildenafil, and riluzole as top candidates for Alzheimer's prevention. Recombinant zoster vaccine linked to...
mRNA Vaccine Technology Beyond COVID: Breakthroughs in

mRNA vaccines beyond COVID-19 in 2026. Cancer vaccines, flu-COVID combos, HIV, and more.
Women's Heart Disease: Why Sex-Specific Differences Lead to Underdiagnosis and Higher Mortality

Heart disease is the #1 killer of women worldwide. Sex-specific differences in symptoms, conditions like SCAD and takotsubo, lead to underdiagnosis and...
CDC Childhood Vaccine Changes: What Parents Need to Know in

CDC reduced universally recommended childhood vaccines from 18 to 11 in 2026. Learn what changed, what the AAP recommends, which vaccines were reclassified,...
Dengue Fever Surges Globally: Climate Change Expands Mosquito Range to New Regions

Dengue cases hit record 12.4 million in 2024 as climate change expands Aedes aegypti range. New endemic areas emerging in Europe and US. WHO declares global...
Hepatitis C Elimination: The 95% Cure and the Race to Meet WHO's 2030 Target

Hepatitis C is now curable in 95%+ of cases with 8-12 week oral DAA treatment. WHO targets elimination by 2030, but approximately 50 million remain...
Gut Microbiome and Health: Major Breakthroughs in

Recent discoveries linking gut microbiome to immunity, mental health, and chronic disease. New precision probiotic therapies show promise.
Opioid Crisis Update: Expanding Buprenorphine Access and Harm Reduction Strategies

US opioid crisis: 81,000+ overdose deaths in 2023. X-waiver eliminated to expand buprenorphine access. Naloxone now available OTC. Harm reduction saves lives.
Blood Thinners: DOACs vs Warfarin and New Alternatives in

Blood thinner comparison 2026. DOACs vs warfarin, Factor XI inhibitors, personalized anticoagulation.
New Anxiety Treatments in 2026: From Psychedelic Medicine to Nerve Stimulation

New anxiety treatments in 2026 include MM120 (psychedelic-derived therapy) for generalized anxiety and vagus nerve stimulation for treatment-resistant...
Folic Acid Fortification: How Flour Enrichment Prevents Neural Tube Defects Worldwide

Folic acid fortification prevents neural tube defects like spina bifida. Over 60 countries mandate flour fortification, preventing an estimated 22,000 NTDs...
Whooping Cough Resurgence: Why Pertussis Cases Are Rising Despite Vaccination

Pertussis cases surged in 2024-2025, with CDC reporting highest US cases since 2014. Waning immunity from acellular vaccines drives resurgence. Boosters...
Norovirus Vaccine Development: Progress Toward Preventing the Stomach Flu

Norovirus causes 685 million cases and 200,000 deaths annually. Vaccine candidates from HilleVax and Moderna show promise but face genotype diversity...
Blood Pressure Targets Debate: Should Hypertension Goals Be Lower Than 140/90?

SPRINT trial showed intensive BP control (<120 mmHg) reduced CVD events by 25%. ACC/AHA and ESC guidelines now recommend lower targets for most adults.
Exercise as Medicine: How Physical Activity Prevents and Treats Chronic Disease

WHO recommends 150 min moderate or 75 min vigorous exercise weekly. Physical inactivity causes 3.2 million deaths/year. Exercise reduces chronic disease risk.
Melanoma Immunotherapy: 10-Year Survival Data Shows Dramatic Improvement with Checkpoint Inhibitors

CheckMate 067 reveals 49% of advanced melanoma patients alive at 10 years with nivolumab plus ipilimumab, a dramatic leap from the historical 5% survival.
Romosozumab for Osteoporosis: How Anti-Sclerostin Therapy Builds Bone and Prevents Fractures

Romosozumab (Evenity) is a dual-action anti-sclerostin antibody building bone while reducing resorption. ARCH trial shows 48% fewer vertebral fractures.
ADHD Medication Update: New Treatments and Guidelines for

2026 ADHD medication guide. New non-stimulants, digital therapeutics, updated guidelines for adults and women.
Lupus Treatment Update: Belimumab, Anifrolumab, and Voclosporin Transform SLE Management

Targeted therapies transform systemic lupus erythematosus treatment. Belimumab, anifrolumab, and voclosporin offer new options for SLE and lupus nephritis.
AI-Assisted Colonoscopy: How Computer-Aided Detection Improves Polyp and Adenoma Detection

AI-assisted colonoscopy systems boost adenoma detection rates by over 40% in meta-analyses. FDA-cleared CADe tools like GI Genius reduce missed polyps in...
Pancreatic Cancer Early Detection: Biomarkers, Liquid Biopsy, and AI Screening Advances

Pancreatic cancer has only 12% five-year survival due to late detection. Liquid biopsy, AI-enhanced imaging, and high-risk surveillance aim to improve outcomes.
Endometriosis Diagnosis: Closing the 7-Year Gap with Biomarkers and Imaging Advances

Endometriosis affects 190 million women globally with an average 7-year diagnostic delay. New biomarkers, imaging, and targeted therapies are transforming care.
Chronic Kidney Disease Screening: Early Detection and SGLT2 Inhibitor Breakthroughs

CKD affects 850 million people globally yet remains underdiagnosed. KDIGO guidelines and SGLT2 inhibitors like dapagliflozin offer new strategies for detection.
Drug-Resistant Tuberculosis: New Regimens Offer Hope Against MDR-TB and XDR-TB

Drug-resistant TB remains a global crisis killing 1.25 million annually. The BPaL regimen shows 89% success in XDR-TB, transforming the hardest-to-treat cases.
GLP-1 Medications for Adolescent Obesity: Wegovy Approval and STEP TEENS Results

FDA-approved GLP-1 medications like Wegovy show major weight loss in adolescents. STEP TEENS trial reports 16.1% BMI reduction vs 0.6% increase with placebo.
Self-Collected HPV Testing Now Accepted for Cervical Cancer Screening

Updated guidelines now accept self-collected HPV testing for cervical cancer screening. Learn how self-collection works, who should get screened, accuracy...
Liquid Biopsy for Cancer Monitoring: How ctDNA Is Transforming Recurrence Detection

Circulating tumor DNA liquid biopsy detects cancer recurrence months before imaging. Used in colorectal and breast cancer to guide adjuvant therapy decisions.
Dementia Prevention: 14 Modifiable Risk Factors That Account for 45% of Cases

The 2024 Lancet Commission identifies 14 modifiable risk factors for 45% of dementia cases. New additions: untreated vision loss and high LDL cholesterol.
Stroke Thrombectomy Extended to 24 Hours: How the DAWN and DEFUSE 3 Trials Changed Treatment

Mechanical thrombectomy for ischemic stroke is now effective up to 24 hours after onset. DAWN and DEFUSE 3 trials dramatically improved outcomes. Time is brain.
Sleep Deprivation and Chronic Disease: Why the AHA Made Sleep Its 8th Health Metric

The AHA added sleep to Life's Essential 8 for cardiovascular health. Short sleep raises all-cause mortality by 12% and diabetes risk significantly. Learn...
Ultra-Processed Foods Linked to Premature Death: What the Lancet Research Shows

Major research links ultra-processed foods to significantly higher mortality and chronic disease risk. Learn which foods to avoid, what the science shows,...
Extreme Heat and Health: Recognizing Heat Illness and Staying Safe

US heat-related deaths reached record levels in 2023 according to the CDC. Learn to recognize heat exhaustion vs heat stroke and essential prevention...
SGLT2 Inhibitors for Heart Failure: A Breakthrough Regardless of Diabetes Status

SGLT2 inhibitors dapagliflozin and empagliflozin reduce heart failure hospitalization by 26%. Now guideline-directed therapy for HFrEF regardless of diabetes.
Preventing Type 2 Diabetes: How Lifestyle Changes Cut Risk by 58%

The Diabetes Prevention Program proved lifestyle intervention reduces type 2 diabetes risk by 58%. Learn about 150 min/week exercise and weight loss goals.
MRI-First Prostate Cancer Screening: How It Reduces Unnecessary Biopsies

MRI-first prostate cancer screening detects clinically significant tumors better than PSA alone and reduces unnecessary biopsies by 28% using PI-RADS.
PFAS in Drinking Water: Health Risks of Forever Chemicals and How to Protect Yourself

The EPA finalized PFAS rules setting 4 ppt limits for PFOA and PFOS in drinking water. Learn about health risks, contamination, and filtration options.
Youth Vaping Crisis: E-Cigarette Health Risks and Regulatory Actions in

With 2.5 million US teens vaping per 2024 NYTS data, health authorities intensify action against youth e-cigarette use amid growing evidence of lung damage.
Telehealth for Chronic Disease: How Virtual Care Improves Outcomes in

Telehealth utilization has grown substantially among US adults, showing significant benefits for diabetes management, hypertension control, and mental...
Gut-Brain Axis: How Your Microbiome Influences Mental Health

Research reveals the gut microbiome's profound influence on mental health through the gut-brain axis, with 95% of serotonin produced in the intestinal tract.
Maternal Mortality Crisis: 287,000 Annual Deaths and Growing Disparities

Global maternal mortality claims 287,000 lives annually, with hemorrhage as the leading cause. The US rate of 22.3 per 100,000 is triple that for Black women.
Long-Acting PrEP With Lenacapavir: How a Capsid Inhibitor Could Reshape HIV Prevention Worldwide

Lenacapavir, a first-in-class capsid inhibitor given twice yearly, demonstrated unprecedented efficacy in PURPOSE trials and may overcome the adherence gap...
Multi-Cancer Blood Test Screening: From Laboratory Promise to Population Health Reality | iMedic

Exploring how multi-cancer early detection blood tests like Galleri are reshaping cancer screening paradigms, the clinical evidence behind cfDNA-based...
Early-Onset Colorectal Cancer: Why Rates Are Rising in Adults Under 50

Colorectal cancer incidence rises 2% annually in adults under 50, prompting the ACS to lower screening recommendations to age 45 and intensify research.
Universal Flu Vaccine: mRNA Approaches Advance in Clinical Trials

Universal influenza vaccine candidates using mRNA technology enter advanced clinical trials, aiming to protect against all flu subtypes and end annual shots.
Lancet Countdown 2025: Climate Change Drives Record Health Threats Worldwide

The Lancet Countdown report reveals record heat-related mortality, expanding vector-borne diseases, and worsening air pollution from climate change.
Mpox Clade Ib Outbreak: WHO Emergency Declaration and Global Update

Mpox clade Ib spreads from DRC to neighboring countries, prompting WHO PHEIC declaration. Jynneos vaccine deployment and transmission reviewed.
GLP-1 Drug Cardiovascular Benefits: SELECT Trial and Beyond

SELECT trial shows semaglutide reduces cardiovascular events by 20% in obesity. GLP-1 drugs show benefits for kidneys, heart failure, and liver disease (MASH).
AI in Medical Diagnosis: FDA-Cleared Devices and Clinical Impact

Over 900 FDA-cleared AI medical devices transform radiology and diagnostics. Deep learning accuracy, validation, and bias concerns reviewed.
Long COVID Research Update: Causes, Treatments, and NIH RECOVER Trial

Long COVID affects 6-7% of infected adults. Latest research on viral persistence, immune dysregulation, microclots, and NIH RECOVER trial treatment results.
Antibiotic Resistance Crisis: WHO Global AMR Report

WHO reports 4.95 million deaths annually linked to antimicrobial resistance. ESKAPE pathogens, stewardship programs, and new antibiotics reviewed.
RSV Vaccines for Older Adults: Second Season Recommendations

Updated CDC guidance on RSV vaccines Arexvy and Abrysvo for adults 60+. Second season recommendations, nirsevimab for infants, and efficacy data.
H5N1 Bird Flu in US Dairy Herds: CDC Surveillance Update

CDC enhances H5N1 bird flu surveillance after HPAI detections in US dairy herds and poultry workers. Pandemic preparedness steps and current risk assessment.

Health News

Articles

FDA Approves Generic Combination Drug for Hypertension and Cholesterol: What Patients Should Know

Why Americans Are Demanding Oral Weight-Loss Pills Over Injections

Deep Brain Stimulation Shows Promise as Treatment for Dementia in Alzheimer's and Parkinson's Disease

Dravet Syndrome Treatment: How New Therapies Are Transforming Quality of Life for Children

Capping Insulin at $35 Per Month Significantly Improves Treatment Adherence in Type 2 Diabetes

Combined Ultrasound and Shockwave Therapy Shows Promise for Knee Osteoarthritis Pain

EMA Backs First Combined Flu-COVID mRNA Vaccine After FDA Declines Review

Antibody-Drug Conjugates: How Targeted Cancer Therapies Are Expanding Beyond Breast Cancer

Should You Skip Your Workout for More Sleep? A Science-Based Guide

Why Women Face Higher Insomnia Risk at Every Stage of Life

Revolutionary Sickle Cell Gene Therapy at Children's Hospital of Philadelphia Leaves Patients Pain-Free

CRISPR Gene-Editing Therapy Safely Lowers Cholesterol and Triglycerides in First Human Trial

Why a Diverse Exercise Routine May Help You Live Longer, According to New Research

Your Gut Microbiome Holds the Key to Anti-Aging: How to Keep It Youthful

How Physical Fitness Shapes the Gut Microbiome in Children: New Cross-Sectional Study

Japanese Drug Targets Cellular Aging: How Senolytic Research Could Transform Longevity Medicine

Exercise Variety Matters: Mixing Activity Types Linked to Lower Mortality Risk

Child Mortality Under Five: Why Progress Is Slowing Despite Proven Interventions

FDA Regulatory Delays and Staff Exodus: How Agency Turmoil Could Affect Drug Approvals

Nipah Virus Vaccine Enters First Human Trial: What This Means for Global Health

Exercise at Work: How Workplace Physical Activity Lowers Chronic Disease Risk

How Just 5 Extra Minutes of Exercise and 10 More Minutes of Sleep Could Lower Heart Disease Risk

Sleep vs. Exercise: Which Matters More for Your Health and How to Balance Both

Baxdrostat Shows Strong Results for Treatment-Resistant High Blood Pressure

3D Bioprinted Cartilage Cell Therapy Shows Promise for Osteoarthritis Treatment

Diabetes Drugs May Slow Cognitive Decline in Early Alzheimer's Patients

Scientists Uncover Why mRNA COVID Vaccines Rarely Trigger Heart Inflammation

Vitamin B12 and Longevity: How This Essential Nutrient Supports Healthy Aging

Peeled Garlic Recalled Over Botulism Risk: What You Need to Know About Clostridium botulinum

Can Exercise Treat Depression as Effectively as Therapy? What the Evidence Shows

Metformin May Mimic Exercise Benefits in Prostate Cancer Patients

Online Mental Health Programs Show Significant Improvement in Depression and Anxiety for MS Patients

New Alzheimer's Drug Approach Targets Brain Rewiring Instead of Plaque Removal

Depression and Anxiety in People Living With HIV: Why Mental Health Screening Is Critical

Hong Kong's New Drug Approval Pathway Could Reshape Global Pharmaceutical Access

Pediatric Cardiomyopathy: Why Identifying the Cause Is Critical for Treatment Success

RNA Interference Therapy for Resistant Hypertension: How a Twice-Yearly Injection Could Replace Daily Pills

Generic Semaglutide Launches in India: What It Means for Diabetes and Weight Loss Treatment

Chronic Kidney Disease in Diabetes: New Research on Early Detection and Prevention

Sleep Medicine Research: How New Discoveries Are Transforming Patient Care

Custom-Made CRISPR Gene-Editing Therapy for Children: A New Era in Personalized Medicine

FDA Dietary Supplement Labeling: What New Regulation Means for Consumer Safety

AI Algorithm Can Now Analyze Physical Activity and Fitness in Children: What Parents Should Know

Mental Health Intervention Reduces Severe Depression and Anxiety in Vulnerable Populations

Texas Children's Hospital Delivers Breakthrough Treatment for Rare Neurological Disorder

Aldosterone Synthase Inhibitors: A New Drug Class for Uncontrolled High Blood Pressure

Colorectal Cancer Research: How Precision Oncology Is Changing Treatment Outcomes

COVID-19 mRNA Vaccines May Spark Immune Response That Fights Cancer, New Research Suggests

Sickle Cell Disease: Specialized Treatment Centers Report Remarkable Pain-Free Outcomes

Japanese Anti-Aging Drug Shows Promise for Fighting Cellular Aging: What We Know

Why a Leading Longevity Researcher Skips Supplements: 3 Evidence-Based Anti-Aging Habits

How Exercise and a Healthy Diet Can Restore Optimal Well-Being as You Age

Menopause Hormone Therapy and Brain Health: What New Research Reveals About Cognitive Protection

Alzheimer's Drug Innovation: How Dual-Target Therapies Are Reshaping Treatment

Gene-Edited Sickle Cell Therapy: How a One-Time Treatment Is Eliminating Pain Crises

Japan Launches First Human Trial of Nipah Virus Vaccine: What You Need to Know

Bipartisan Insulin Cost Cap Bill: What It Means for Millions With Diabetes

Personalized mRNA Cancer Vaccines: How Pandemic Technology Is Transforming Oncology

Preventive Circadian Medicine: Why Doctors Are Now Recommending Sleep Checkups

First Personalized CRISPR Therapy Saves Infant Life in Historic Gene Editing Milestone

Scientists Identify Key Protein That Drives Brain Aging — and a Way to Block It

Eli Lilly's New Oral Weight-Loss Pill: What Patients Need to Know About the FDA Approval

Video Gaming Linked to Better Cognitive Performance in Children, NIH Research Finds

WHO Announces Influenza Vaccine Composition for Northern Hemisphere Season: What You Need to Know

Childhood Brain Cancer Research Breakthrough Could Transform Pediatric Treatment

FDA Approves Avlayah for Neurologic Hunter Syndrome: A Breakthrough for Rare Disease Patients

Depression and Anxiety in Opioid Dependence: How Psychosocial Factors Shape Treatment Outcomes

FDA Approves Kresladi: First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I

Vivid Dreams May Be the Secret to Deeper, More Restful Sleep, New Research Suggests

Gender-Affirming Treatments Linked to Reduced Depression and Anxiety: New Retrospective Study

Programmable DNA Smart Drug Targets Cancer Cells With Unprecedented Precision

Type 2 Diabetes Remission Through Lifestyle Changes: What the Evidence Shows in

Fasting-Mimicking Diet Shows Promise for Crohn's Disease: What the New Trial Found

New Cholesterol-Lowering Drugs and Gene Therapy: Cardiovascular Breakthroughs in

Pet Longevity Industry Surges: Anti-Aging Drugs and GLP-1 Treatments Now Target Dogs and Cats

Driving With Arthritis: How to Stay Safe and Comfortable Behind the Wheel

Gut Microbiome Blood Markers May Detect Cognitive Decline Early: What the New Research Shows

New Drug for Severe Childhood Epilepsy: How It Is Transforming Treatment in